UNISOM Drug Patent Profile
✉ Email this page to a colleague
When do Unisom patents expire, and when can generic versions of Unisom launch?
Unisom is a drug marketed by Pfizer and Chattem and is included in two NDAs.
The generic ingredient in UNISOM is doxylamine succinate. There are fourteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the doxylamine succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Unisom
A generic version of UNISOM was approved as doxylamine succinate by PERRIGO on September 18th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for UNISOM?
- What are the global sales for UNISOM?
- What is Average Wholesale Price for UNISOM?
Summary for UNISOM
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 95 |
| Clinical Trials: | 2 |
| Patent Applications: | 1,394 |
| DailyMed Link: | UNISOM at DailyMed |
Recent Clinical Trials for UNISOM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hospira, now a wholly owned subsidiary of Pfizer | Phase 4 |
| Hospira, Inc. | Phase 4 |
| University of Pennsylvania | Phase 4 |
US Patents and Regulatory Information for UNISOM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | UNISOM | doxylamine succinate | CAPSULE;ORAL | 019440-001 | Feb 5, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chattem | UNISOM | doxylamine succinate | TABLET;ORAL | 018066-001 | Approved Prior to Jan 1, 1982 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
